%0 Figure %A Tel, Jurjen %A Koornstra, Rutger %A Haas, Nienke %A Deutekom, Vincent %A Westdorp, Harm %A Boudewijns, Steve %A Erp, Nielka %A Blasio, Stefania %A Gerritsen, Winald %A Figdor, Carl %A Vries, I. %A Hato, Stanleyson %D 2016 %T MOESM2 of Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition %U https://springernature.figshare.com/articles/figure/MOESM2_of_Preclinical_exploration_of_combining_plasmacytoid_and_myeloid_dendritic_cell_vaccination_with_BRAF_inhibition/4377944 %R 10.6084/m9.figshare.c.3615911_D3.v1 %2 https://springernature.figshare.com/ndownloader/files/7104077 %K Vemurafenib %K DC vaccination %K Plasmacytoid DCs %K BDCA1 + myeloid DCs %X Additional file 2: Fig S2. Indicated immune cell subsets were cultured in increasing concentrations of vemurafenib and cell viability was determined after 24 h by FACS analysis. Shown is the mean (+SEM) of three independent experiments. %I figshare